Medical Affairs 360 white logo
  • Services
  • Publications
  • COMPANY NEWS
  • CLIENTS
  • About
  • Contact Us
Medical Affairs 360 Announces Poster Presentations from the 2026 Tandem Meetings

Medical Affairs 360 Announces Poster Presentations from the 2026 Tandem Meetings

by Medical Affairs 360 | Mar 14, 2026 | Clinical Development, Success Stories

San Diego, CA.  March 14, 2026 – Medical Affairs 360 LLC, a medical advisory firm offering services to pharmaceutical and biotechnology companies, is pleased to announce two Poster Presentations completed from the 2026 Tandem Meetings (Transplantation &...
Medical Affairs 360 Announces Regimmune Poster Presentations at the 2026 Tandem Meeting

Medical Affairs 360 Announces Regimmune Poster Presentations at the 2026 Tandem Meeting

by Medical Affairs 360 | Dec 23, 2025 | Clinical Development, Success Stories

San Diego, CA. December 23, 2025 – Medical Affairs 360 LLC, a medical advisory firm offering services to pharmaceutical and biotechnology companies, is pleased to announce the acceptance of two Posters to be presented at the 2026 Tandem Meeting (Transplantation...
Medical Affairs 360 Supports Regimmune’s Landmark Publication on RGI-2001 in Blood Journal

Medical Affairs 360 Supports Regimmune’s Landmark Publication on RGI-2001 in Blood Journal

by Medical Affairs 360 | Oct 23, 2025 | Clinical Development, Success Stories

San Diego, CA.  October 23, 2025 – Medical Affairs 360 LLC, a medical advisory firm offering services to pharmaceutical and biotechnology companies, is pleased to announce the major publication in the current issue of Blood (The Journal of the American Society...
Medical Affairs 360 Congratulates Loxo Oncology on Its Acquisition by Eli Lilly

Medical Affairs 360 Congratulates Loxo Oncology on Its Acquisition by Eli Lilly

by Medical Affairs 360 | Jan 7, 2019 | Drug Safety Analytics & Pharmacovigilance, Success Stories

San Diego, CA.  January 7, 2019 – Medical Affairs 360 LLC, a medical advisory firm offering services to pharmaceutical and biotechnology companies, is pleased to congratulate its client partner, Loxo Oncology, Inc., on its acquisition by Eli Lilly and Company in...

Recent Posts

  • Medical Affairs 360 Announces Poster Presentations from the 2026 Tandem Meetings
  • Medical Affairs 360 Announces Regimmune Poster Presentations at the 2026 Tandem Meeting
  • Medical Affairs 360 Supports Regimmune’s Landmark Publication on RGI-2001 in Blood Journal
  • Medical Affairs 360 Congratulates Loxo Oncology on Its Acquisition by Eli Lilly

Recent Comments

No comments to show.

CAREERS

Medical Affairs 360 © 2026 | Privacy Policy | Terms of Use

Website by CreativeBrandHaus.com